Herceptin : new treatment and new questions.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017277:Drug Approval; D005260:Female; D006801:Humans; D008403:Mass Screening; D018579:Patient Selection; D018719:Erb-b2 Receptor Tyrosine Kinases; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases